[USE OF A PROTEOLYTIC ENZYME-ACETYLSALICYLIC ACID COMBINATION IN OBSTETRICS AND COMPARISON OF THE THERAPEUTIC RESULTS WITH THOSE OBTAINED BY A PLACEBO].
D001241:Aspirin; D035843:Biomedical Research; D002918:Chymotrypsin; D005260:Female; D006801:Humans; D006867:Hydrolases; D007743:Labor, Obstetric; D009774:Obstetrics; D010447:Peptide Hydrolases; D010919:Placebos; D011247:Pregnancy; D014357:Trypsin
D010919:Placebos; D006867:Hydrolases; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D014357:Trypsin; D001241:Aspirin
ASPIRIN; CHYMOTRYPSIN; CLINICAL RESEARCH; LABOR; PLACEBOS; PREGNANCY; TRYPSIN
UTILISATION DE L'ASSOCIATION ENZYMES PROT'EOLYTIQUES-AC. AC'ETYL SALICYLIQUE EN OBST'ETRIQUE ET COMPARAISON DES R'ESULTATS TH'ERAPEUTIQUES OBTENUS PAR RAPPORT 'A UN PLACEBO.